ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2669

TLR7 Ligation Contributes to Monocyte Migration in Rheumatoid Arthritis

Nathan D. Chamberlain1, Seung-jae Kim1, Michael Volin2, William Swedler3, Suncica Volkov1 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine Midwestern University, Downers Grove, IL, 3Section of Rheumatology, University of Illinois at Chicago, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Inflammation, macrophages, monocytes and rheumatoid arthritis, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis II: Cellular Effectors of Rheumatoid Arthritis and Novel Rheumatoid Arthritis Genome-Wide Association Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose: The aim of the study was to characterize the expression of TLR7 in rheumatoid arthritis (RA) peripheral blood (PB) cells and to examine the pathogenic role of TLR7 ligation in RA.

Methods: Expression of TLR7 was determined in RA and normal (NL) PB monocytes and in vitro differentiated macrophages by real-time RT-PCR and/or flow cytometry. Next the endogenous TLR7 ligand was identified in RA synovial fluid and its ability to induce monocyte migration was determined by in vitro chemotaxis.

Results: Since we have previously shown that expression of TLR7 was elevated in RA synovial lining and sublining macrophages, we asked whether expression of TLR7 was increased in RA PB and synovial fluid macrophages compared to NL PB monocytes and differentiated macrophages. We show that expression of TLR7 was elevated 18 and 24 fold in RA synovial fluid macrophages compared to RA and NL PB differentiated macrophages respectively by real-time RT-PCR. Levels of TLR7 were 6 and 3 fold higher in RA monocytes compared to RA differentiated macrophages and NL monocytes. Interestingly, mRNA and endosomal expression of TLR7 are reduced when RA PB monocytes differentiate to macrophages. Ligation of TLR7 by a synthetic agonist in RA blood monocytes is responsible for production of high levels of TNF-a (3 ng/ml) and as such we demonstrate that levels of TLR7 and TNF-a in 35 RA monocytes strongly correlate with each other (R2=0.44, p=1.37×10-5) and disease activity score (TLR7 and DAS28 correlation; R2=0.67, p=1.57×10-9) suggesting a pathogenic role for TLR7 ligation in RA disease. In light of elevated levels of TLR7 in RA synovial fluid macrophages, we looked for TLR7 endogenous ligands in RA synovial fluid. We discovered that single strand (ss)RNA extracted from RA synovial fluid is a potential TLR7 endogenous ligand, since blockade of TLR7 ligation by TLR7 antagonist in RA monocytes greatly downregulates synovial fluid ssRNA mediated TNF-a transcription. To determine whether TLR7 ligation affects cell trafficking in the RA joint, monocyte chemotaxis was examined in response to a synthetic agonist to TLR7. We show that TLR7 ligation was chemotactic for monocytes beginning at 0.1 ng/ml of TLR7 agonist. Next, studies were performed to determine if the TLR7 ligation affects RA synovial fluid mediated monocyte extravasation. We document that blockade of TLR7 ligation or degradation of synovial fluid ssRNA is equally effective in reducing synovial fluid induced monocyte trafficking and that the combined therapy does not have an enhanced effect suggesting that ligation of joint ssRNA to TLR7 modulates monocyte extravasation through an overlapping pathway and it further points out that RA synovial fluid ssRNA is a potential TLR7 ligand.

Conclusion: We identify, for the first time, TLR7 endogenous ligand in RA joint and we also document a novel role for TLR7 ligation in RA monocyte migration.


Disclosure:

N. D. Chamberlain,
None;

S. J. Kim,
None;

M. Volin,
None;

W. Swedler,
None;

S. Volkov,
None;

S. Shahrara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr7-ligation-contributes-to-monocyte-migration-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology